Valvular Heart Disease
VHD Verified · Sep 2026Valvular heart disease (VHD) is any malfunction of one or more of the four heart valves — the flaps fail to open fully (stenosis) or to close fully (regurgitation) — so blood flow is obstructed or leaks backward, straining the heart chamber behind the valve.
The disorder behind the crescendo-decrescendo murmur that radiates to the neck, the aortic stenosis triad, the opening snap and diastolic rumble, the mechanical-valve INR and its valve click, the dentist-first rule — and the reason a quieter murmur can be bad news.
What’s going wrong in the body
The normal physiology, where it fails, and why the body’s compensation backfires.
01 Two ways a valve fails — and two ways a ventricle answers
The four valves (tricuspid, pulmonary, mitral, aortic) open and close to keep blood moving in one direction; if one does not open or close correctly, flow is disturbed and the heart is strained. There are two functional lesions. In stenosis the flaps become thick, stiff, or fused so the valve cannot open all the way. In regurgitation the flaps fail to seal and blood leaks backward — when the flaps bulge or flop back into the chamber behind them, that is prolapse, most often of the mitral valve. A valve can be both stenotic and regurgitant at once, and a congenital valve with no opening at all is atresia.
The ventricle behind each lesion remodels according to the load it is handed, and that fork organizes the whole topic. Stenosis is pressure overload: the ventricle pumps against a fixed obstruction, so the wall thickens inward — concentric hypertrophy — as in the concentric LV hypertrophy of aortic stenosis. Regurgitation is volume overload: each beat the ventricle must handle the regurgitant volume plus the forward volume, so the chamber stretches and dilates with eccentric hypertrophy, as in chronic aortic regurgitation, where eccentric hypertrophy develops and chamber dilation ensues, and chronic mitral regurgitation, where volume overload dilates the ventricle.
Turbulent flow across a failed valve is what you hear. A murmur is the blowing, whooshing, or rasping sound of rapid, choppy blood flow, and its timing tells you which lesion is present: a systolic murmur falls between S1 and S2 (holosystolic = throughout systole), a diastolic murmur falls after S2 and before S1. Intensity is graded I–VI: grade I is faint and barely audible, grade III is easily audible without a thrill, and grade IV is easily audible with a palpable thrill (V and VI are heard with the stethoscope barely touching or off the chest). Not every murmur is disease — innocent flow murmurs are mid-systolic, come from increased cardiac output in childhood and pregnancy, cause no symptoms, and resolve on their own.
02 The aortic valve — the fixed door of stenosis and the leaking door of regurgitation
Aortic stenosis (AS) obstructs left-ventricular outflow — a jet velocity of at least 2 m/s across the valve separates true stenosis from mere sclerosis (thickening without a gradient). The cascade runs: obstruction → higher LV systolic pressure and a prolonged ejection time → increased afterload → concentric LV hypertrophy → diastolic dysfunction and fibrosis. The hypertrophied wall demands more oxygen (higher pressure, more mass, longer ejection) while its perfusion time shrinks, so LV function deteriorates with rising oxygen consumption and falling supply. That mismatch explains the classic triad. Angina: the thick myocardium needs more oxygen than compressed coronaries can deliver, with or without coronary disease. Syncope: on exertion the body vasodilates, but the stenotic valve passes only a fixed cardiac output, so arterial pressure falls and the brain is under-perfused. Dyspnea: the stiff ventricle raises its end-diastolic pressure, which transmits backward as pulmonary venous hypertension and pulmonary edema.
The sound of AS is a mid-systolic crescendo-decrescendo ejection murmur heard best at the second right intercostal space, radiating to the right neck and carotids, with a slow-rising, late-peaking, low-amplitude carotid upstroke (pulsus parvus et tardus) in severe disease and an S4 from the hypertrophied ventricle. The trap that matters at the bedside: murmur intensity softens when the LV fails or stroke volume falls — a quieter murmur with a falling blood pressure is a failing ventricle, not improvement. Under 70 the usual cause is a congenital bicuspid valve (present in about 1% of the population); over 70 it is calcific degeneration of a normal three-leaflet valve, which is why AS affects up to 10% of people past 80. The latent period lasts roughly 10–20 years, and then the symptoms arrive together with the prognosis: without valve replacement, mortality after symptom onset exceeds 90% within a few years, with average survival of only about 1–3 years, and the risk of sudden cardiac death climbs. No drug slows AS; the only fix is a new valve.
Aortic regurgitation (AR) is the mirror image: blood runs back from the aorta into the LV during diastole. Chronically, the regurgitant volume raises end-diastolic volume, the LV hypertrophies eccentrically and dilates, and for years a huge stroke volume keeps the patient well. That big stroke volume distends the peripheral arteries and raises systolic pressure while diastolic run-off back into the ventricle drops diastolic pressure — the wide pulse pressure with a low diastolic BP and the bounding, collapsing water-hammer (Corrigan) pulse, head bobbing (de Musset), and nail-bed pulsation (Quincke). The murmur is a high-frequency early diastolic decrescendo blowing murmur at the third-to-fourth left intercostal space (longer means more severe); in severe AR the regurgitant jet strikes the anterior mitral leaflet and produces the Austin Flint murmur, a low-pitched mid-to-late diastolic rumble at the apex — which mimics mitral stenosis but has no opening snap. When compensation fails, sarcomeres are maximally stretched and fibrosis drops LV compliance. Acute AR (aortic dissection, endocarditis, trauma) is different and deadly: a non-dilated LV cannot accept the sudden volume, end-diastolic pressure spikes, the mitral valve closes prematurely, and pulmonary edema and cardiogenic shock follow — a surgical emergency in which the intra-aortic balloon pump is contraindicated because balloon inflation raises aortic diastolic pressure and worsens the leak.
03 The mitral valve — the atrial dam of stenosis and the feedback loop of regurgitation
Mitral stenosis (MS) narrows the mitral orifice, impairing LV filling, raising left atrial pressure, and producing progressive pulmonary congestion. The normal mitral annulus is about 4–6 cm²; flow is impeded once the area falls below 2 cm². The stenotic valve passes blood only in diastole, so anything that shortens diastole — tachycardia, atrial fibrillation, pregnancy, fever, anemia, exertion — raises the transmitral gradient and the left atrial pressure behind it; symptoms appear or worsen with anything that raises the heart rate. Three chains follow. Rhythm: chronic pressure stretches and enlarges the left atrium, which breeds atrial fibrillation; AF removes the atrial kick that a stenotic valve depends on for LV filling, so new AF can precipitate sudden congestive heart failure, and blood pooling in the enlarged atrium forms thrombus — the embolic stroke that makes anticoagulation part of MS care. Lungs: left atrial pressure transmits backward as pulmonary venous hypertension, pulmonary edema, and exertional dyspnea; engorged bronchial veins rupture and cause hemoptysis; reactive pulmonary hypertension eventually fails the right ventricle (JVD, hepatomegaly, ascites, peripheral edema).
The exam of MS is a set piece: a loud S1, an opening snap shortly after A2 (the abrupt tensing of the stenotic valve — the A2–snap interval shortens as stenosis worsens), and a low-pitched mid-diastolic rumbling murmur with presystolic accentuation, heard best with the bell at the apex in the left lateral decubitus position. The presystolic accentuation disappears once AF removes atrial contraction. Blood pressure is most often normal. Worldwide the cause is rheumatic heart disease — commissural fusion, leaflet thickening, subvalvular fibrosis — developing years to decades after the rheumatic episode (commonly 10–20 years, sometimes as early as 5–10), most often in women; in developed nations degenerative mitral annular calcification also causes it. Once pulmonary hypertension develops, average survival without intervention is about 3 years, whereas valve replacement gives roughly 80% survival at 10 years.
Mitral regurgitation (MR) sends blood backward from the LV into the LA during systole, producing a holosystolic blowing murmur at the apex that radiates to the left axilla, often with an S3 and a displaced apical impulse. Primary (organic) MR is structural leaflet, chordal, or papillary disease — most commonly mitral valve prolapse from myxomatous degeneration, which gives a mid-systolic click and a murmur that gets longer and louder on standing (less preload, earlier prolapse). Secondary (functional) MR is a structurally normal valve pulled open by a dilated, dysfunctional ventricle after ischemic or dilated cardiomyopathy. Chronic MR is a positive-feedback loop: volume overload dilates the ventricle, dilation widens the annulus, the wider annulus worsens leaflet coaptation, and the leak grows. The ejection fraction rises at first because the LV unloads into the low-pressure atrium — so a "normal" EF of 60% in MR already means LV dysfunction — and later LA enlargement, AF, and LV failure follow. Acute MR (papillary muscle rupture in 1–2% of patients after MI, chordal rupture, endocarditis) hits a non-compliant atrium that cannot buffer the volume: a precipitous fall in cardiac output, flash pulmonary edema, and cardiogenic shock — a new holosystolic murmur after an MI is papillary rupture until proven otherwise.
04 Where diseased valves come from — rheumatic fever — and what grows on them — endocarditis
Acute rheumatic fever (ARF) is an abnormal immune response to group A Streptococcus infection, most commonly pharyngitis, arriving about 2–4 weeks after the strep infection. The mechanism is molecular mimicry: streptococcal M protein and related antigens cross-react with cardiac myosin, a type 2 hypersensitivity reaction that leaves Aschoff nodules in the heart. Carditis occurs in 50–80% of ARF, the mitral valve is involved in 50–60% with regurgitation usually the earliest lesion, the aortic valve in about 20%, the tricuspid in about 10% (only alongside left-sided disease), and the pulmonary valve rarely. ARF strikes mainly children aged 5–15; rheumatic heart disease (RHD) then peaks diagnostically in young adults aged 20–39, with the highest burden in Oceania, sub-Saharan Africa, and South Asia, and roughly 470,000 new ARF cases and 233,000 attributable deaths each year. Diagnosis uses the revised Jones criteria (2015): two major, or one major plus two minor, plus evidence of preceding strep infection (ASO or anti-DNase B titers, throat culture, or rapid antigen test) — major criteria are carditis, polyarthritis, Sydenham chorea, erythema marginatum, and subcutaneous nodules; minor are fever, arthralgia, elevated ESR/CRP, and a prolonged PR interval.
RHD is preventable at two points. Primary prevention is treating strep pharyngitis promptly — the WHO 2024 guideline strongly recommends penicillin (intramuscular or oral) as first line. Secondary prevention stops recurrences that scar the valve further: benzathine penicillin G 1.2 million units IM every 4 weeks (every 3 weeks in high-risk populations) or oral penicillin V, continued for 5 years or until age 21 without carditis, 10 years or until 21 after carditis without residual disease, and 10 years or until age 40 when carditis left residual valve disease. WHO names IM benzathine penicillin the preferred first-line approach for anyone with prior RF or RHD — the only cost-effective one.
A diseased or prosthetic valve is also the surface infective endocarditis (IE) needs. Turbulent flow across the abnormal valve injures the endothelium, platelets and fibrin lay down a sterile vegetation, and a transient bacteremia — oral flora after dental manipulation, IV lines, injection drug use — seeds it into a bacterial biofilm shielded from immune defenses. The people at highest risk are exactly the ones who get dental prophylaxis: prosthetic valves and prosthetic repair material (including TAVR valves), prior IE, unrepaired cyanotic congenital heart disease, and transplant valvulopathy. On a valve patient, fever plus a new or changed murmur is IE until the cultures say otherwise, and a new conduction block means a perivalvular abscess. Prosthetic valve endocarditis carries the highest mortality of any IE — one more reason the dentist comes before the new valve.
Causes & risk factors
Modifiable factors are teaching targets — the patient can act on them.
Signs & symptoms
Each finding tied to the mechanism that produces it — and the triage it calls for.
Diagnostics
Complications
Medications for this condition
Why each class is prescribed here — every card links to its full pharmacology page.
Valve disease is a clot-forming disease at two sites: the enlarged fibrillating left atrium of mitral stenosis and the foreign surface of a mechanical prosthesis. Warfarin is the anticoagulant of choice for both — MS with AF, a prior embolus, or LA thrombus (INR about 2.5) and every mechanical valve for life: target 2.5 (2.0–3.0) for a mechanical aortic valve without risk factors, 3.0 (2.5–3.5) for a mechanical mitral valve or any mechanical valve with risk factors, plus low-dose aspirin 75–100 mg (per the 2020 ACC/AHA guideline as reported by Ryu & Tran 2022). DOACs are contraindicated with mechanical valves — the RE-ALIGN trial of dabigatran was stopped early for excess stroke and bleeding, because dabigatran blocks thrombin alone while warfarin blocks factors VII, IX, X, and II — and are not recommended in rheumatic MS. Bioprosthetic valves need warfarin only 3–6 months while the sewing ring endothelializes, then aspirin; after TAVR aspirin is the long-term default, and an AF patient may keep the original anticoagulant. Perioperatively, mechanical-valve patients are bridged with heparin, never simply stopped.
In mitral stenosis beta-blockers are first-line rate control: a stenotic mitral valve passes blood only in diastole, so slowing the heart prolongs diastolic filling and lowers the transmitral gradient with exertion; they also control the ventricular rate once AF arrives. In aortic stenosis the same drug is used cautiously — the fixed obstruction limits the compensation a slowed, weakened ventricle can mount. In acute AR they are avoided outright: blocking the compensatory tachycardia lengthens diastole and lets more blood regurgitate. In secondary MR and rheumatic heart failure they are part of guideline-directed HF therapy as tolerated.
Symptom relief for the congestion every lesion eventually produces — pulmonary venous congestion and peripheral edema in MS, heart-failure symptoms in AS, AR, and MR. They are not disease-modifying: no diuretic changes a valve. In aortic stenosis avoid excessive volume depletion — the thick, stiff, preload-dependent LV needs filling pressure to push blood through the fixed valve, and over-diuresis drops cardiac output and blood pressure.
Afterload and blood-pressure control where the ventricle, not the valve, is the problem: guideline-directed therapy for the LV dysfunction behind secondary (functional) MR, hypertension and HFrEF in chronic AR (vasodilators may slow progression but do not replace surgery), and heart failure in rheumatic heart disease. In aortic stenosis ACE inhibitors are for hypertension only — avoid excessive vasodilation, because the fixed valve cannot raise output to defend the pressure — and they do not slow AS progression; no drug does.
Beyond medications
- Aortic valve replacement (AVR) is recommended for symptomatic severe AS even when symptoms are mild (Stage D), and for asymptomatic severe AS with LVEF < 50%, an abnormal exercise test, very severe or rapidly progressing disease, or other planned cardiac surgery. LVEF often recovers and hypertrophy regresses over 18 months to 5 years afterward. Balloon aortic valvuloplasty gives only short-term benefit — a bridge or palliation, not a fix.
- TAVR vs SAVR — per current guidance as summarized by StatPearls, TAVR is favored for patients about 75 or older or at high surgical risk and is a primary option from about 70 when transfemoral access is suitable, while SAVR stays preferred for younger, low-risk patients because TAVR durability beyond 10–15 years is still under study; TAVR is not offered when noncardiac life expectancy is under 12 months. TAVR is for stenosis only, never regurgitation; the valve is delivered through the femoral artery under TEE guidance, with a shorter hospital stay and faster recovery than a sternotomy.
- Mechanical vs bioprosthetic valve: mechanical valves are the most durable (about 25 years) but demand lifelong warfarin and INR checks; bioprosthetic (porcine or bovine pericardial) valves avoid lifelong anticoagulation but deteriorate after about 10–15 years, longer in older recipients, and are chosen when anticoagulation is contraindicated or INR monitoring is unavailable. The direction is younger → mechanical, older → bioprosthetic, shared decision between (StatPearls cites under 50 vs over 70).
- Repair before replacement: repair carries fewer risks, so it is preferred whenever feasible — the mitral valve is most commonly repaired (annuloplasty ring, leaflet reconstruction), the aortic most commonly replaced. Severe primary MR gets surgery when symptomatic (EF > 30%) or when asymptomatic with EF 30–60% or LV end-systolic diameter ≥ 40 mm; transcatheter edge-to-edge repair (MitraClip/TEER) serves high-surgical-risk primary MR and.
- Percutaneous balloon mitral commissurotomy (PBMC) is first line for symptomatic severe rheumatic MS (valve area ≤ 1.5 cm²) with favorable morphology (Wilkins < 8), no LA thrombus, and no more than mild MR: transseptal access and an Inoue balloon split the fused commissures. Follow-up echo a few days later and yearly; more than a third need reintervention within 5–10 years, anticoagulation continues if AF is present, and unfavorable anatomy, LA thrombus, or significant MR sends the patient to surgery.
- Rheumatic prevention: penicillin for strep pharyngitis (WHO 2024, first line) and secondary prophylaxis with benzathine penicillin G 1.2 million units IM every 4 weeks (3 weeks in high-risk populations) — 10 years or until age 40 when carditis left residual valve disease. Endocarditis treatment is 4–6 weeks of IV bactericidal antibiotics (at least 6 weeks for a prosthetic valve), often completed at home, with surgery in about half.
- Lifestyle: heart-healthy, sodium-restricted diet; blood-pressure control; stop smoking; treat high cholesterol, diabetes, obesity, and inactivity; balance activity with rest; dental exams and cleaning every 6 months.
Nursing considerations
The RN-specific layer — each action paired with the reason it matters.
How a real nurse thinks
The clinical-judgment loop, worked for a typical presentation — reasoning, not reference.
- 1 Recognize cues
The cues that matter: a syncopal episode on exertion, two months of exertional chest tightness and dyspnea — the full aortic stenosis triad — sitting on top of a crescendo-decrescendo murmur at the aortic area radiating to the carotids with a slow, weak carotid upstroke and an S4. The echo confirms it: jet velocity above 4.0 m/s, gradient above 40 mm Hg, valve area at or below 1.0 cm² is severe AS by the 2020 ACC/AHA thresholds as reported by StatPearls, with concentric hypertrophy and a still-preserved EF. The noise: normal vitals and clear lungs. The trap is the reassuring EF — a normal LVEF does not soften this picture; the symptoms do the staging.
- 2 Analyze cues
Severe AS plus any symptom is Stage D, and this patient has all three. The syncope has a mechanism you can explain to him: on the stairs his muscles vasodilated, but the stenotic valve could pass only a fixed cardiac output, so his arterial pressure fell and his brain was under-perfused. The chest tightness with a negative troponin is the hypertrophied wall outstripping its coronary supply, not an infarct. The markedly elevated BNP and the S4 are the stiff, pressure-loaded ventricle talking. This is the prognosis cliff — without valve replacement, survival after symptom onset averages about 1–3 years with a real risk of sudden death — so the reasoning shifts from "watch the murmur" to "get him to a new valve."
- 3 Prioritize
The dangerous outcomes today are another exertional syncope with a fall and a sudden death event, then decompensation into heart failure. Priority one is protecting him from exertion and from abrupt vasodilation while he waits: no hallway workouts, assisted ambulation only, and cautious use of the PRN nitroglycerin. Priority two is flagging the exercise stress test order — exercise testing unmasks symptoms in asymptomatic AS but is avoided once symptoms exist, which is exactly his case. Priority three is making sure cardiology hears the full triad and the echo numbers so the valve conversation (TAVR versus SAVR at 78) starts now.
- 4 Generate solutions
Fall and activity precautions with an explanation he can repeat back — stop and sit at the first breathlessness, dizziness, or chest pain. Continuous telemetry stays on: LVH with calcium reaching the septum can produce conduction delays. For the PRN nitroglycerin: give it only with him seated, with a BP before and after, and hold and call if he is hypotensive or lightheaded — the sources say use cautiously, not never. Call the resident to clarify the stress test and the cardiology team with an SBAR. Anticipate a heart-team evaluation with cardiac CT for annular sizing and surgical-risk and frailty scoring; at 78 he sits in the 65–80 band where either transfemoral TAVR or surgical AVR is a shared decision (per the 2020 ACC/AHA guideline as reported by Barbanti & Costa 2021), and he will need a dental check before any prosthesis.
- 5 Take action
Act, then call: bed alarm on, call light within reach, "walk only with staff" explained and posted, nitroglycerin plan written into the MAR notes. Then the SBAR: "78-year-old admitted after exertional syncope, two months of exertional angina and dyspnea; grade III/VI crescendo-decrescendo murmur radiating to the carotids; ED echo Vmax 4.4 m/s, mean gradient 48, AVA 0.8 cm², EF 55%; BNP over 3× normal. This is symptomatic severe aortic stenosis — I am requesting that the morning exercise stress test be cancelled and that cardiology see him today for valve-replacement evaluation." The trap to avoid: letting him "build up strength" in the hall or handing over nitroglycerin without a BP check — both drop the pressure a fixed valve cannot defend.
- 6 Evaluate
Success by the end of the shift: stress test cancelled, cardiology consult done and heart-team workup ordered, no exertional symptoms, no falls, BP stable after any nitroglycerin. Reassess the murmur and BP each round with the deterioration cue memorized in advance: a softer murmur with a falling blood pressure is not improvement — it is the LV failing, and crackles, frothy sputum, or a new S3 mean pulmonary edema behind the fixed valve. Either is a rapid-response call, not a note for the morning. Before discharge or transfer for the procedure, he and his family can state the three symptoms that always mean stop and call, and why his dentist appointment comes before his new valve.
Scenario — you’re the nurse
Work each question before revealing the answer. Rationales explain the wrong options too.
A 78-year-old man admitted after fainting while carrying groceries up a flight of stairs. History: hypertension, hyperlipidemia; a heart murmur "noted at a physical years ago" that was never followed up. He tells you that for about two months he has had chest tightness and breathlessness climbing stairs that eases when he stops. Orders: continuous telemetry, cardiology consult, and — from the covering resident — an exercise stress test for the morning.
Q1 Select all that apply Which admission findings require follow-up? Select all that apply. - A. Syncope while climbing stairs
- B. Systolic murmur at the 2nd right intercostal space radiating to the carotids
- C. Chest tightness with exertion for two months
- D. Blood pressure 122/76
- E. Exercise stress test ordered for the morning
Reveal answer & rationale
Q2 Multiple choice The patient asks, "Why do I faint on the stairs? My blood pressure is fine when I sit here." The best explanation is: - A. "Your heart rhythm becomes irregular when you climb, and the irregular beats drop your pressure."
- B. "When you exert yourself your blood vessels open up, but your narrowed valve can only let a fixed amount of blood through, so your pressure and the blood flow to your brain fall."
- C. "Your heart muscle has become too thin and weak to pump against the stairs."
- D. "The murmur means blood is leaking backward into your heart with every step."
Reveal answer & rationale
Q3 Put in order At 1830 the patient is found walking back from the bathroom alone, holding the rail, saying his chest feels tight and he is "a little dizzy." Place the nurse’s actions in priority order: - A. Notify the provider with an SBAR, including the symptom, vitals, and the events leading up to it
- B. Stop the activity — seat him immediately in the nearest chair, then return him to bed with assistance
- C. Obtain a full set of vital signs, auscultate the murmur and lungs, and check the telemetry rhythm
- D. Document the event and reinforce the walk-only-with-staff plan
Reveal answer & rationale
Q4 Multiple choice On the 2300 assessment the nurse notes the murmur is noticeably softer than at 1500, and the BP is 94/58 with new bibasilar crackles. The nurse should interpret this as: - A. Improvement — the obstruction is easing and the murmur is resolving
- B. An expected response to bed rest and the earlier nitroglycerin
- C. Left ventricular failure — falling stroke volume is quieting the murmur and backing fluid into the lungs; activate a rapid response
- D. Mitral stenosis — a softening systolic murmur means the lesion has shifted to the mitral valve
Reveal answer & rationale
Q5 Select all that apply The heart team recommends a valve. The patient asks the difference between the two types. Which statements should the nurse include? Select all that apply. - A. A mechanical valve lasts the longest but requires warfarin for the rest of your life with regular INR checks
- B. A biological (tissue) valve usually needs warfarin only for the first few months, then daily aspirin
- C. A biological valve wears out over roughly 10–15 years, and tends to last longer in older recipients
- D. With a mechanical valve you can switch from warfarin to a newer blood thinner that needs no blood tests
- E. Whichever valve you receive, you will need an antibiotic before dental procedures that involve the gums
Reveal answer & rationale
Common questions
What causes valvular heart disease?
What are the early signs of valvular heart disease?
Which findings should a nurse report immediately in valvular heart disease?
Why does aortic stenosis cause angina, syncope, and shortness of breath?
What INR does a patient with a mechanical heart valve need, and why not a DOAC?
Who needs antibiotics before the dentist?
Sources
- Aortic Stenosis — StatPearls — StatPearls (NCBI Bookshelf)
- Mitral Stenosis — StatPearls — StatPearls (NCBI Bookshelf)
- Infective Endocarditis — StatPearls — StatPearls (NCBI Bookshelf)
- DOACs in Mechanical and Bioprosthetic Heart Valves: A Narrative Review (Ryu & Tran, 2022) — carrier for the 2020 ACC/AHA INR targets — Clinical and Applied Thrombosis/Hemostasis (PMC)
- WHO guideline on the prevention and diagnosis of rheumatic fever and rheumatic heart disease (2024) — World Health Organization (NCBI Bookshelf)
- Transcatheter Aortic Valve Replacement (TAVR) — StatPearls — StatPearls (NCBI Bookshelf)
- Cardiac Surgery — StatPearls — StatPearls (NCBI Bookshelf)
- Mechanical Aortic Valve Replacement — StatPearls — StatPearls (NCBI Bookshelf)
- Warfarin — StatPearls — StatPearls (NCBI Bookshelf)
- Endocarditis — MedlinePlus — MedlinePlus (NLM)
Reviewed by Hae Suk Lee, RN
Educational summary for nursing students. Scenarios are fictional teaching cases. Always verify against current guidelines and your institution's protocols before acting in practice. Not medical advice.